Physician profile
Brandon A Cincere
NPI 1679694434
$22,314.26
in general payments reported to CMS, 2019-2025
14 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,192 · 2021: $5,127 · 2022: $1,651 · 2023: $1,180 · 2024: $439 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,135 · Travel and Lodging: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,135.37 |
| Travel and Lodging | $869.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $9,697.38 | 2019-2022 | |
| Arthrex, INC. | $7,180.45 | 2019-2023 | |
| Smith+Nephew, INC. | $3,071.24 | 2019-2025 | Healicoil, Q-Fix, Multifix |
| Innovation Technologies INC | $1,220.74 | 2021-2025 | Irrisept |
| Smoky Mountain Surgical LLC | $658.47 | 2023-2024 | |
| Lifenet Health | $95.85 | 2024 | Allograft Vmis Delivery System |
| Horizon Therapeutics Plc | $83.19 | 2019-2021 | |
| Acera Surgical, INC. | $78.38 | 2025 | Restrata Wound Matrix |
| Access Pro Medical, LLC | $53.55 | 2025 | Matriderm |
| Prosidyan, INC | $53.40 | 2021 | |
| Avanos Medical | $44.32 | 2022 | |
| Linvatec Corporation | $32.84 | 2022 | |
| Djo, LLC | $32.05 | 2024 | Cmf |
| Ferring Pharmaceuticals INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Cincere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.